These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 2471770)

  • 101. Proliferative and/or cytotoxic activity of lymphocyte clones to autologous human melanoma.
    Fossati G; Anichini A; Squarcina P; Mazzocchi A; Parmiani G
    Int J Cancer; 1988 Aug; 42(2):239-45. PubMed ID: 2969867
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Recognition of keratinocytes by cytotoxic T cells specific for conventional HLA class-I alloantigen.
    Symington FW; Santos EB
    J Invest Dermatol; 1990 Aug; 95(2):224-8. PubMed ID: 2116484
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Functionally different HTLV I-infected T cell lines with the same phenotype derived from a patient with melanoma.
    Sivanandham M; Mukherji B
    Immunol Lett; 1989 Dec; 23(2):149-54. PubMed ID: 2576655
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Proliferative and cytotoxic responses of human peripheral blood lymphocytes to autologous malignant effusions. An analysis at the clonal level.
    Roberts TE; Shipton U; Moore M
    Cancer Immunol Immunother; 1986; 22(2):107-13. PubMed ID: 2941144
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.
    Saitoh S; Kurisaka M; Mori K; Maeda N; Fujimoto S
    Jpn J Cancer Res; 1997 Mar; 88(3):289-95. PubMed ID: 9140114
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Augmentation of interleukin-2-induced activation of human melanoma tumor-infiltrating lymphocytes by heteroconjugate antibody.
    Mansfield PF; Rosenblum MG; Murray JL; Itoh K
    Cancer Immunol Immunother; 1991; 33(4):247-54. PubMed ID: 1829394
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Extrathymic development and function of human T-lymphocytes from bone marrow cells in vitro.
    Adibzadeh M; Bühring HJ; Daikeler T; Siegels-Hübenthal P; Owsianowsky M; Schenk A; Rehbein A; Schaudt K; Schlotz E; Pohla H
    Cell Immunol; 1994 Mar; 154(1):25-42. PubMed ID: 8118889
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells.
    Coulie PG; Somville M; Lehmann F; Hainaut P; Brasseur F; Devos R; Boon T
    Int J Cancer; 1992 Jan; 50(2):289-97. PubMed ID: 1730522
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Segregation of effector mechanisms in a tumour-specific CD8+ T-cell clone correlates with CD30 expression.
    Sun Y; Song M; Maeurer MJ; Schadendorf D
    Scand J Immunol; 2001 Sep; 54(3):314-20. PubMed ID: 11555396
    [TBL] [Abstract][Full Text] [Related]  

  • 110. A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells.
    Yssel H; Spits H; de Vries JE
    J Exp Med; 1984 Jul; 160(1):239-54. PubMed ID: 6204000
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Human cytotoxic CD8+ T-lymphocyte clones engraft in severe combined immunodeficient (SCID) mice but show diminished function.
    de Kroon JF; van Bergen CA; de Paus RA; Kluin-Nelemans HC; Willemze R; Falkenburg JH
    J Immunother; 1997 Mar; 20(2):101-10. PubMed ID: 9087382
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Autoreactive T-cell clones which suppress cytotoxic T cell responses.
    Sakatsume M; Harada Y; Ling X; Yasumoto A; Kurosu A; Koseki H; Saito T; Kantake M; Taniguchi M
    Int Immunol; 1991 Apr; 3(4):377-84. PubMed ID: 1831655
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Cytotoxic human HLA class II restricted purified protein derivative-reactive T-lymphocyte clones. IV. Analysis of HLA restriction pattern and mycobacterial antigen specificity.
    Hansen PW; Petersen CM; Povlsen JV; Kristensen T
    Scand J Immunol; 1987 Mar; 25(3):295-303. PubMed ID: 3494302
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Cytotoxic T lymphocyte mediated recognition of human pancreatic cancer cells.
    Peiper M; Sato T; Streichert T; Eisenberger CF; Knoefel WT; Izbicki JR
    Int J Cancer; 2002 May; 99(1):88-92. PubMed ID: 11948497
    [TBL] [Abstract][Full Text] [Related]  

  • 115. In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.
    Sun Y; Möller P; Berking C; Schlüpen EM; Volkenandt M; Schadendorf D
    Immunology; 1999 Dec; 98(4):535-40. PubMed ID: 10594685
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
    Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
    Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
    [TBL] [Abstract][Full Text] [Related]  

  • 117. CD4+ cytolytic T cell clones restricted to HLA class II, DR beta I, and DR beta III chains.
    Noguchi M; Hozumi N; Nisbet-Brown E
    Cell Immunol; 1989 Oct; 123(1):96-107. PubMed ID: 2570646
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.
    Slingluff CL; Darrow T; Vervaert C; Quinn-Allen MA; Seigler HF
    J Natl Cancer Inst; 1988 Sep; 80(13):1016-26. PubMed ID: 3261800
    [TBL] [Abstract][Full Text] [Related]  

  • 119. High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene.
    Baurain JF; Colau D; van Baren N; Landry C; Martelange V; Vikkula M; Boon T; Coulie PG
    J Immunol; 2000 Jun; 164(11):6057-66. PubMed ID: 10820291
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Modulation of in vitro autologous melanoma-specific cytotoxic T-cell responses by phorbol dibutyrate and ionomycin.
    Darrow TL; Quinn-Allen MA; Crowley NJ; Seigler HF
    Cell Immunol; 1990 Feb; 125(2):508-17. PubMed ID: 2297796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.